Skip to main content
Clinical Trials/NCT05794828
NCT05794828
Completed
Early Phase 1

Erector Spinae Regional Anesthesia for Pain Control in the Emergency Department

The University of Texas Health Science Center at San Antonio3 sites in 1 country15 target enrollmentSeptember 15, 2023

Overview

Phase
Early Phase 1
Intervention
Bupivacaine Injection
Conditions
Pain Management
Sponsor
The University of Texas Health Science Center at San Antonio
Enrollment
15
Locations
3
Primary Endpoint
Pain Scale Rating
Status
Completed
Last Updated
8 months ago

Overview

Brief Summary

Interventional study to use erector spinae plane block (ESPB) on diagnoses of posterior or lateral rib fractures, vertebral fractures, pancreatitis, pancreatic cancer, renal colic, and back pain for multimodal pain therapy to determine its assistance with pain relief as well as the patient's use of opiates after block completion

Detailed Description

Patients with the listed diagnoses will be offered and then consented for an ESPB under ultrasound guidance. They will rate their pain before and 30 minutes after the procedure using the ordinal categorical data on a numeric pain scale. Total patient opiate use will be gathered up to 8 hours after block completion.

Registry
clinicaltrials.gov
Start Date
September 15, 2023
End Date
February 18, 2025
Last Updated
8 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Posterior/lateral rib or vertebral fractures
  • Pancreatitis or pancreatic cancer
  • Renal colic
  • Back pain

Exclusion Criteria

  • Unstable vitals
  • Infection or open wound over insertion site
  • Prior allergic reaction to local anesthetic
  • Pregnant females
  • Patients \<18 years old
  • Altered mentation

Arms & Interventions

Erector Spinae Plane Block (ESP) administration

Patients with the listed diagnoses will be offered and then consented for an ESPB under ultrasound guidance.

Intervention: Bupivacaine Injection

Outcomes

Primary Outcomes

Pain Scale Rating

Time Frame: Baseline to study procedure end (approximately 30 minutes)

Change in pain scale rating assessed by the participants on a scale from 0-10 with 0 indicating no pain and 10 indicating the most severe pain.

Study Sites (3)

Loading locations...

Similar Trials